Page 235 - Veterinary Toxicology, Basic and Clinical Principles, 3rd Edition
P. 235

202 SECTION | II Organ Toxicity




  VetBooks.ir  plants that stimulate these receptors including Nicotiana sp.  paralysis which results in death within 3 10 days. Signs
                                                                are symmetric and progress from the pelvic limbs toward
             (varying types of tobacco), Conium maculatum or poison
                                                                the thoracic limbs. Cranial nerves may be affected, possi-
             hemlock, and Lobelia or Indian tobacco. The numerous
             alkaloids present in these plants as well as the cyano-  bly resulting in megaesophagus, decreased jaw tone,
             bacterial toxin anatoxin-a, most commonly produced by  facial paralysis and/or a decreased gag reflex. Autonomic
             Anabaena flos-aquae (Roder, 2004c), exert their neuro-  functions may be affected as well (Coleman, 1998). The
             toxic effects by initially stimulating nicotinic choliner-  disease is called limber neck in affected birds. In human
             gic and neuromuscular junction receptors but ultimately  patients who have been supported with artificial respira-
             result in a persistent neuromuscular blocking effect.  tion, the duration of the effect has been documented to
             Signs include muscular weakness, tremors, nausea,  persist for 6 8 months (Kotsonis et al., 2001).
             vomiting, ataxia, tachypnea, tachycardia, hypertension,  The prognosis for severely affected animals is at best
             mydriasis, staggering, seizures, respiratory failure, and  guarded, but more realistically, poor. Treatment can
             death (Panter, 2004a,b,c). Treatment is symptomatic and  include debridement of wounds, penicillin therapy, and
             supportive. Prognosis is good except in cases of large  antitoxin (5 mL IV or IM) within the first 5 days of expo-
             overdoses.                                         sure. Administration of the antitoxin does not reverse the
                Imidacloprid (Advantage) is a chloronicotinyl nitro-  clinical signs attributed to neurons already affected by the
             guanide insecticide marketed for flea control in pets and  toxin. Because of its equine source and antigenicity, an
             which exerts its effects via possibly both agonist and  intradermal test dose is recommended prior to full admin-
             antagonist actions at the nicotinic ACh receptor. Death of  istration IV or IM. For individuals already severely
             the insect is effected via the same clinical signs as  affected, assisted ventilation is indicated until the patient
             previously described above, yet imidacloprid has a wide  can breathe spontaneously, yet the duration of therapy
             margin of safety in mammals due to its poor systemic  required may not be practical in veterinary medicine.
             absorption when applied dermally (as labeled) (Craig  Extreme supportive care, including assisted or parenteral
             et al., 2005) and due to the higher affinity of imidacloprid  feeding, physical therapy, manual evacuation of the blad-
             for insect nicotinic receptors versus mammalian receptors.  der and intermittent manipulation of body position to pre-
             Acute oral ingestions are usually limited to nausea, saliva-  vent hypostatic congestion and formation of decubital
             tion, and vomiting (Wismer, 2004).                 ulcers, is critical. Some laboratories can confirm the diag-
                Another mechanism by which ACh can be involved in  nosis with analysis of serum, gut contents, and/or feed for
             toxicoses is the lack of release of the neurotransmitter  the preformed toxin (Roder, 2004b; Bailey, 2006). A
             from the presynaptic terminal. Botulinum toxin, produced  mouse inoculation assay and type-specific ELISA testing
             by the anaerobic bacterium Clostridium botulinum, exerts  may also aid in the diagnosis of botulism (Thomas, 1991).
             its action via this mechanism. Sources of the toxin include
             ingestion of food contaminated with either preformed  Catecholamine Neurotransmitters
             toxin or clostridial spores, contamination of a puncture
             wound with spores, and ingestion of spores from the envi-  Catecholamines are “fight or flight” neurotransmitters
             ronment. Exposure can be oral, inhaled, or absorbed cuta-  that include norepinephrine, epinephrine and dopamine.
             neously through devitalized skin (Bailey, 2006). The  Their synthesis begins with conversion of the amino acid
             toxin consists of a 100 kDa heavy chain and a 50 kDa  L-tyrosine to L-dopa. Removal of a carboxyl group from
             light chain linked by disulfide and noncovalent bonds.  L-dopa forms dopamine which is acted upon by dopamine
             Upon ingestion of the toxin, its heavy chain binds synap-  β-hydroxylase to form norepinephrine (Spencer, 2000).
             totagmin, a presynaptic vesicle protein. Once the toxin is  Norepinephrine is also stored in the adrenal medulla and
             internalized within the presynaptic terminal, its disulfide  released into the blood with sympathetic stimulation
             bonds are cleaved, releasing the light chain. The free light  (Capen, 2001). N-methylation of norepinephrine forms
             chain is then available to cleave proteins that are respon-  epinephrine, an adrenal hormone, which is only nominally
             sible for the docking and release of ACh vesicles into the  present in the brain. Catecholamines are inactivated by
             synapse.                                           monoamine oxidase (MAO) and catechol-O-methyltrans-
                Seven different botulinum toxins (A G) have been  ferase (COMT) enzymes (Beasley, 1999; Spencer, 2000).
             described. Types C and D are most commonly associated  In addition to its role at postganglionic sympathetic
             with veterinary species (type C is most common in dogs);  neurons, norepinephrine also mediates effects in the CNS.
             types A, B, E and F have caused disease in humans.  Adrenergic receptors include α 1 , α 2 , β 1 and β 2 receptors.
             Although differences exist regarding which proteins are  Stimulation of α 1 adrenergic receptors, present peripher-
             cleaved by each toxin type, the end result is the lack of  ally,  results  in  vasoconstriction  and  mydriasis.
             ACh in the synaptic cleft of the neuromuscular junction  Stimulation of α 2 adrenergic receptors, present in the
             (Roder, 2004b). The clinical result is a progressive flaccid  CNS, mediates inhibition of norepinephrine, resulting in
   230   231   232   233   234   235   236   237   238   239   240